Buy Crypto
Pay with
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Markets
Trade
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
U.S. Stocks
CFD
U.S. stock CFD derivatives
Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
GUSD
Mint GUSD for Treasury RWA yields
Earn
Launch
CandyDrop
tag
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investment
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
More
Promotions
AI
Others
TradFi
Rewards
Square
Latest
Hot
News
Profile
CoinNetwork

Crypto World Network news reports that XBIT DEX said that APompliano and his guest discussed why the stock market keeps setting new highs even in bad news, why AI and biotechnology are undervalued, and how Eli Lilly’s AI collaborations could change the outlook for longevity and chronic diseases. In addition, the discussion covered how to reasonably allocate investment portfolios in an era of exponential growth.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 10
  • 2
  • Share
Comment
Add a comment
Add a comment
GateUser-715706bb
· 3h ago
The biggest fear in the era of exponential growth is using old maps to find new lands; the approach to configuration needs to change.
View OriginalReply0
GoToSleepAfterMinting
· 5h ago
If Eli Lilly's AI collaboration truly materializes, the valuation system for pharmaceutical stocks will need to be rewritten.
View OriginalReply0
MintLiquidationWarning
· 5h ago
Is biotechnology underestimated? I think the market is still waiting for a blockbuster.
View OriginalReply0
SlippageSiren
· 5h ago
Exponential growth sounds exciting, but the pullback can also be quite painful.
View OriginalReply0
ColdBrewSparklingWater
· 5h ago
Chronic diseases + aging, this demand is incredibly rigid.
View OriginalReply0
AirdropTaxPanic
· 5h ago
How can ordinary people get on board with Longevity Technology? Please show the way.
View OriginalReply0
TheWindBeneathTheCyberBridge
· 5h ago
In configuring combinations, being scattered is not as good as choosing the right narrative.
View OriginalReply0
MoonlightLiquidationLine
· 5h ago
AI is now like the internet back in the day, full of opportunities and full of pitfalls.
View OriginalReply0
StargazerInTheWoods
· 5h ago
The decoupling of the stock market from fundamentals is something seasoned investors are no longer surprised by.
View OriginalReply0
ExitLiquidityPoet
· 5h ago
AI + biotechnology has indeed been underestimated this time; Eli Lilly's strategic planning is far-sighted.
View OriginalReply0
View More

  • Pinned

Sitemap